Sigma Planning Corp Agenus Inc Call Options Transaction History

Sigma Planning Corp

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 10, 2022	SELL	$1.96 - $3.14 $7,644 - $12,246	-3,900 Reduced 21.79%	14,000 $29,000
Q2 2022 Aug 11, 2022	BUY	$1.3 - $2.64 $5,330 - $10,824	4,100 Added 29.71%	17,900 $35,000
Q4 2021 Feb 02, 2022	BUY	$2.92 - $5.74 $6,424 - $12,628	2,200 Added 18.97%	13,800 $44,000
Q3 2021 Oct 28, 2021	BUY	$4.98 - $6.63 $57,768 - $76,908	11,600 New	11,600 $61,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Sigma Planning Corp with notifications on news.